| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Medicine, University of California-San Diego, La Jolla, California 92093; the Department of Cell Biology and Physiology, Washington University School of Medicine (M.M.), St. Louis, Missouri 63110; and the Veterans Administration Research Service (J.M.O.), San Diego, California 92161
Address all correspondence and requests for reprints to: Jerrold M. Olefsky, M.D., Department of Medicine (0673), University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093-0673.
| Abstract |
|---|
|
|
|---|
S), into 3T3-L1
adipocytes. Thirty minutes after the injection of 5 mM
GTP
S, 40% of injected cells displayed surface GLUT4 staining
indicative of GLUT4 translocation compared with 55% for
insulin-treated cells and 10% in control IgG-injected cells. Treatment
of the cells with the phosphatidylinositol 3-kinase inhibitor
wortmannin or coinjection of GST-p85 SH2 fusion protein had no effect
on GTP
S-mediated GLUT4 translocation. On the other hand, coinjection
of antiphosphotyrosine antibodies (PY20) blocked GTP
S-induced GLUT4
translocation by 65%. Furthermore, microinjection of GTP
S led to
the appearance of tyrosine-phosphorylated proteins around the periphery
of the plasma membrane, as observed by immunostaining with PY20.
Treatment of the cells with insulin caused a similar
phosphotyrosine-staining pattern. Electroporation of GTP
S stimulated
2-deoxy-D-glucose transport to 70% of the extent of
insulin stimulation. In addition, immunoblotting with phosphotyrosine
antibodies after electroporation of GTP
S revealed increased tyrosine
phosphorylation of several proteins, including 70- to 80-kDa and 120-
to 130-kDa species. These results suggest that GTP
S acts upon a
signaling pathway either downstream of or parallel to activation of
phosphatidylinositol 3-kinase and that this pathway involves
tyrosine-phosphorylated protein(s). | Introduction |
|---|
|
|
|---|
To further clarify the mechanisms of GLUT4 translocation, we examined
the effect of the nonhydrolyzable GTP analog, guanosine
5'-O-(3-thiotriphosphate) (GTP
S), on GLUT4 translocation.
GTP
S has been reported to stimulate glucose transport and GLUT4
translocation in insulin-responsive cells such as rat adipocytes (2, 3), 3T3-L1 adipocytes (4), and cardiac myocytes (5). It has previously
been shown that treatment of permeabilized 3T3-L1 adipocytes with a
PI-3 kinase inhibitor, wortmannin, only partially inhibits
GTP
S-induced GLUT4 translocation (6). Therefore, the effect of
GTP
S may converge on the insulin signaling pathway downstream of
PI-3 kinase, which couples to GLUT4 translocation. In the present
study, using immunofluorescence detection of GLUT4 proteins, we show
that microinjection of GTP
S into living intact 3T3-L1 adipocytes
stimulates GLUT4 translocation. GTP
S-induced GLUT4 translocation is
not affected by treatment of the cells with wortmannin or coinjection
of a GST fusion protein comprised of the SH2 domain of the p85 subunit
of PI-3 kinase. To clarify the possible role of tyrosine
phosphorylation in this PI 3-kinase-independent GLUT4 translocation, we
examined the relationship between GTP
S-induced GLUT4 translocation
and phosphotyrosine proteins using microinjection and electroporation
techniques.
| Materials and Methods |
|---|
|
|
|---|
S, Lucifer yellow, and all other reagents were
purchased from Sigma Chemical Co. (St. Louis, MO). Electroporation
equipment for adherent cells (Epizap System) was obtained from Ask
Science Products (Ontario, Canada).
Cell culture and microinjection
3T3-L1 cells were cultured and differentiated as previously
described (1). Microinjection of various reagents was carried out using
a semiautomated Eppendorf microinjection system. Cells on glass
coverslips were serum starved for 2 h, microinjected within 30
min, and fixed 30 min after microinjection unless otherwise indicated.
All reagents except PY20 were coinjected with 10 mg/ml sheep IgG for
identification of injected cells.
Immunostaining and fluorescence microscopy
GLUT4 staining. Immunostaining of GLUT4 was performed
essentially as previously described (1). The cells were fixed in 3.7%
formaldehyde in PBS for 10 min at room temperature. After washing, the
cells were permeabilized and blocked with 0.1% Triton X-100 and 2%
FCS in PBS for 10 min. The cells were then incubated with F349 (1
µg/ml) in PBS with 2% FCS overnight at 4 C. After washing, GLUT4 and
injected IgG were detected by incubation with FITC-conjugated donkey
antirabbit IgG antibody and AMCA-conjugated donkey antisheep or
antimouse IgG antibody, respectively, followed by observation under
immunofluorescence microscope. In all counting experiments, each
coverslip was blindly examined, and the AMCA-positive microinjected
cells on each coverslip were evaluated for the presence of plasma
membrane-associated GLUT4 staining.
Phosphotyrosine staining. Cells were fixed and permeabilized as described above and incubated with mouse monoclonal antiphosphotyrosine antibody (PY20; 20 µg/ml) in PBS with 5% FCS overnight at 4 C. After washing, phosphotyrosine and microinjected cells were identified by incubation with FITC-conjugated donkey antimouse IgG antibody and AMCA-conjugated donkey antisheep IgG antibody, respectively.
Electroporation
Electroporation of adherent 3T3-L1 adipocytes plated on
indium-tin oxide-coated conductive glass (9, 10) was performed using
Epizap System (Ask Science Products) essentially according to the
manufacturers instructions. Briefly, on days 78 of differentiation,
3T3-L1 adipocytes were plated on a conductive surface glass slide with
a 10 x 32-mm insulating frame and cultured until the cells were
fully differentiated. After washing the cells with PBS, an electrode
was placed on top of the cells, and 5 mM GTP
S dissolved
in PBS was added between the electrode and the cells. An electrical
pulse was applied at 50 V with a capacitor setting of 47 µF. One
minute after the pulse, cells were incubated in
MEM containing 0.1%
BSA at 37 C for the indicated times. With these settings, more than
90% of the cells incorporated the fluorescent dye, Lucifer yellow.
Electroporation with PBS only had no effect on cell viability, GLUT4
staining, or 2-deoxy-D-glucose uptake (data not shown).
2-Deoxy-D-glucose uptake
Glucose transport was measured by a modification of the methods
described by Klip et al. (11). After electroporation, 3T3-L1
adipocytes were incubated in
MEM containing 0.1% BSA in the absence
or presence of 100 ng/ml insulin for 1 h at 37 C. Glucose uptake
was determined after the addition of 60 µl substrate [0.1 µCi
2-deoxy-D-[3H]glucose; final concentration,
0.01 mM] for 5 min at 25 C.
Immunoblotting
At the indicated times after electroporation, 3T3-L1 adipocytes
were lysed in RIPA buffer containing 20 mM Tris-HCl (pH
7.5), 140 mM NaCl, 1% Nonidet P-40, 1 mM EDTA,
1 mM sodium orthovanadate, 50 U/ml aprotinin, 1
mM phenylmethylsulfonylfluoride, and 50 mM
sodium fluoride. Laemmli buffer containing 5% 2-mercaptoethanol was
added and boiled for 5 min. Each sample containing 60 µg protein was
subjected to SDS-7.5% PAGE and transferred onto nitrocellulose
filters. The filters were incubated with horseradish
peroxidase-conjugated phosphotyrosine antibody (RC20) or PY20, and
subsequently with horseradish peroxidase-conjugated antimouse IgG
antibody. Chemiluminescence was detected with the ECL system (Amersham,
Arlington Heights, IL).
| Results |
|---|
|
|
|---|
S results in GLUT4 translocation in 3T3-L1
adipocytes
S, followed by immunostaining with anti-GLUT4
antibody. Untreated cells display GLUT4 staining mostly localized
around the nucleus, with some staining distributed throughout the
cytoplasm (Fig. 1A
S caused redistribution of GLUT4 with a staining pattern
indistinguishable from that caused by insulin (Fig. 1
S, the percentage of cells
displaying surface GLUT4, indicative of translocation, was 40% at 15
min and declined after 45 min (Fig. 2
S in the subsequent experiments.
|
|
S-induced GLUT4 translocation is not blocked by inhibition of
PI 3-kinase
S-induced glucose transport is only partially inhibited by the
PI-3 kinase inhibitor wortmannin in permeabilized cells (6). In our
study also, treatment of the cells with 1 µM wortmannin,
which completely inhibited insulin-induced GLUT4 translocation (Fig. 3
S (Fig. 3
S-induced GLUT4
translocation. We have previously shown that microinjection of GST-p85
SH2 inhibits both insulin-induced mitogenesis (8) and insulin-induced
GLUT4 translocation (1). Coinjection of this GST-SH2 fusion protein
with GTP
S into 3T3-L1 adipocytes had no effect on GLUT4
translocation (Fig. 1
S-induced
GLUT4 intracellular targeting.
|
S-induced GLUT4 translocation
S-induced GLUT4
translocation, we coinjected PY20 with GTP
S into 3T3-L1 adipocytes
and evaluated GLUT4 staining of each injected cell. Each coverslip
injected with the various reagents was blindly evaluated and counted
for GLUT4 translocation-positive cells. The results revealed that
coinjection of PY20 significantly inhibited GTP
S-induced GLUT4
translocation by 65% (Fig. 1
S-induced GLUT4 translocation (Fig. 4A
S-induced GLUT4 translocation. Microinjection of PY20 inhibited
the effect of GTP
S on GLUT4 translocation in a dose-responsive
manner when injected at concentrations ranging from 2.510.0 mg/ml
(Fig. 4B
S-induced GLUT4 translocation (Fig. 4B
|
S
S-induced GLUT4
translocation indicates that one or more tyrosine-phosphorylated
proteins are involved in the GTP
S mechanism. Thus, we next
examined the effect of GTP
S on phosphotyrosyl staining, as assessed
by indirect immunofluorescence microscopy with the PY20 antibody. In
the unstimulated state, specific staining with PY20 was hardly observed
throughout the cell (Fig. 5A
S, the injected cells displayed discrete punctate
staining with PY20 around the periphery of the plasma membrane (Fig. 5
S-injected cells
(Fig. 5D
|
S stimulates glucose transport and induces tyrosine
phosphorylation of 70- to 80-kDa and 120- to 130-kDa proteins
S, we performed
electroporation of GTP
S into monolayer 3T3-L1 adipocytes, followed
by measurements of glucose transport and immunoblotting with
phosphotyrosine antibodies. Compared with the cells electroporated with
PBS only, introduction of GTP
S stimulated
2-deoxy-D-glucose uptake of the cells by 2.8-fold, which
was 69% of the insulin effect (Fig. 6
S was successfully introduced into the cells,
and that the subsequent translocation of GLUT4 to the cell surface was
functionally significant, leading to increased uptake of glucose.
Electroporation with other nucleotides, i.e. GTP or ATP, had
no effect on glucose transport, and the effects of GTP
S plus insulin
were equal to those of insulin alone (data not shown). Immunoblotting
of the cell lysates revealed that electroporation with GTP
S
stimulated protein tyrosine phosphorylation (Fig. 7A
S was inhibited in a
dose-dependent manner by the tyrosine kinase inhibitor genestin, but
not by wortmannin (not shown). In contrast, electroporation with PBS,
GTP, or ATP was without significant effect on these proteins (Fig. 7
S (Fig. 7C
|
|
| Discussion |
|---|
|
|
|---|
S into 3T3-L1 adipocytes stimulates GLUT4 translocation and
that this effect was not blocked by inhibition of PI 3-kinase enzymatic
activity or targeting of PI 3-kinase to its intracellular sites of
action. However, the effect of GTP
S was blocked by coinjection of
antiphosphotyrosine antibodies. We also used an electroporation system
to show that GTP
S can stimulate both glucose transport and protein
tyrosine phosphorylation. Although it has been known that GTP
S can
stimulate glucose transport, the novel findings in this paper are that
GTP
S can do this by mediating GLUT4 translocation in 3T3-L1
adipocytes, that GTP
S acts in the signaling pathway either
downstream of or parallel to PI 3-kinase, and that its effects are
dependent on the induction of one or more downstream
phosphotyrosine-containing proteins.
GTP
S is a poorly hydrolyzed GTP analog that can bind to various
classes of GTP-binding proteins, converting them to the active
GTP-bound form. Alternatively, binding of GTP
S can inactivate other
classes of guanosine triphosphatases by inhibiting their
GTP-hydrolyzing function. Thus, it is possible that GTP-binding
proteins activated or inactivated by GTP
S could stimulate exocytosis
or inhibit the endocytosis of GLUT4 proteins. Indeed, evidence for both
stimulation of exocytosis and inhibition of endocytosis has been
reported (3). Recently, a role of heterotrimeric G proteins in insulin
signaling has been suggested, as transgenic mice expressing antisense
RNA to Gi
2 display insulin resistance (23). In these
mice, deficiency of Gi
2 leads to an increase in protein
tyrosine phosphatase activity and attenuation of insulin-stimulated
tyrosine phosphorylation of IRS-1 (23). Therefore, the effect of
Gi
2 appears to lie upstream of that of PI 3-kinase. As
our results show that the effect of GTP
S is independent or
downstream of PI 3-kinase, it seems unlikely that GTP
S-induced GLUT4
translocation is mediated through stimulation of Gi
2.
GTP
S could potentially activate Ras protein, but we have previously
demonstrated that p21ras is not necessary
for GLUT4 translocation (1), making this also an unlikely target of
GTP
S in mediating GLUT4 translocation. Other classes of GTP-binding
proteins include members of the Rho and Rab families. Rab family
members could be potentially stimulated by binding GTP
S, and they
have been implicated in various steps of vesicle trafficking (24). In
fact, evidence exists implicating Rab4 in insulin-induced GLUT4
translocation, consistent with the possibility that Rab4 is a target of
GTP
S in this system (25, 26, 27). Another GTP-binding protein, dynamin,
which functions by hydrolyzing GTP to GDP, has been implicated in
clathrin-mediated endocytosis (28). Thus, inactivation of dynamin-like
guanosine triphosphatase by binding to GTP
S may block endocytosis of
GLUT4, leading to an increased amount of GLUT4 on the plasma
membrane.
Several reports have indicated that PI 3-kinase is a critical component
of insulin-induced GLUT4 translocation (1, 6, 18, 19, 20, 21, 22). Thus, using the
single cell microinjection system, we have shown that introducing a GST
fusion protein containing an SH2 domain of the p85 subunit of PI
3-kinase into 3T3-L1 adipocytes inhibits insulin-stimulated GLUT4
translocation (1), presumably by behaving as an intracellular
competitive inhibitor of the binding of endogenous PI 3-kinase to its
proper intracellular targets. In addition, wortmannin, which inhibits
the enzymatic activity of the p110 catalytic subunit of PI 3-kinase,
also inhibits insulin-stimulated glucose transport and GLUT4
translocation (6, 20), whereas expression of a constitutively active
form of the p110 stimulates GLUT4 translocation (22). However, the
current studies clearly demonstrate that the GTP
S effect on GLUT4
redistribution was not inhibited by treating cells with wortmannin or
coinjecting cells with GST-p85 SH2. Therefore, neither the enzymatic
activity of PI 3-kinase nor its proper intracellular targeting are
necessary for the GTP
S effect, indicating that GTP
S acts
downstream of PI 3-kinase or in a pathway completely parallel to that
of PI 3-kinase.
It has previously been established that microinjection of
antiphosphotyrosine antibodies can block insulin-induced DNA synthesis
in fibroblasts as well as GLUT4 translocation in 3T3-L1 adipocytes (1),
and this is consistent with the general idea that activation of the
insulin receptor tyrosine kinase with subsequent phosphorylation of
receptor substrates such as IRS-1, IRS-2, Shc, and Gab1 leads to
activation of a signaling cascade that includes the Ras/MAP kinase and
PI 3-kinase pathways (12, 13, 14, 15). However, our observation that
coinjection of antiphosphotyrosine antibodies effectively blocks
GTP
S-induced GLUT4 translocation indicates that additional tyrosine
phosphorylation events, independent of the insulin receptor kinase, are
necessary for the effects of GTP
S and might also be involved in
insulin-induced GLUT4 translocation.
To further pursue the role of phosphotyrosine proteins in the GTP
S
effect, we assessed tyrosine phosphorylation events by immunostaining
cells with antiphosphotyrosine antibodies using immunofluorescence
detection. In basal cells, no phosphotyrosine staining was observed.
Upon microinjection of GTP
S, clustering of phosphotyrosine staining
appeared in a discrete, punctate distribution at the periphery of the
plasma membrane. Insulin stimulation of cells induced a similar
phosphotyrosine-staining pattern, although the intensity was somewhat
less than that induced by GTP
S. We extended this observation by
performing antiphosphotyrosine immunoblotting of cell lysates prepared
from GTP
S-electroporated cells. We found that GTP
S induced the
tyrosine phosphorylation of several proteins, including one at 7080
kDa and another at 120130 kDa. It is reasonable to suggest that the
phosphotyrosine proteins that appear after GTP
S might be involved in
GLUT4 translocation, and this certainly is consistent with the fact
that microinjection of antiphosphotyrosine antibodies inhibits the
effect of GTP
S on GLUT4 distribution. In this regard, GTP
S did
not cause tyrosine phosphorylation of the insulin receptor ß-subunit
or IRS-I/II, and this coupled with the finding that the effects of
GTP
S on glucose transport were not inhibited by wortmannin or
microinjection of the p85 SH2 domain indicate that GTP
S stimulates
glucose transport through a tyrosine phosphorylation event downstream
of (or parallel to) the insulin receptor and IRS-I/II, and independent
of PI3 kinase.
In summary, we have demonstrated that GTP
S can directly lead to
GLUT4 translocation in 3T3-L1 adipocytes, and that this effect is
mediated by a signaling pathway downstream of or parallel with the
activation and targeting of PI 3-kinase. Furthermore, we have shown
that the GTP
S effect is dependent on tyrosine-phosphorylated
proteins. The specific GTP-binding protein(s) and the downstream
tyrosine-phosphorylated proteins involved in this process remain to be
defined.
| Footnotes |
|---|
Received June 24, 1997.
| References |
|---|
|
|
|---|
-toxin-permeabilized rat adipose cells.
J Biol Chem 266:40374040
S and localization of GLUT4 to clathrin lattices. J Cell Biol 117:11811196
2. Nature 379:840844[CrossRef][Medline]
This article has been cited by other articles:
![]() |
T. Ijuin and T. Takenawa SKIP Negatively Regulates Insulin-Induced GLUT4 Translocation and Membrane Ruffle Formation Mol. Cell. Biol., February 15, 2003; 23(4): 1209 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Kralik, P. Liu, B. J. Leffler, and J. S. Elmendorf Ceramide and Glucosamine Antagonism of Alternate Signaling Pathways Regulating Insulin- and Osmotic Shock-Induced Glucose Transporter 4 Translocation Endocrinology, January 1, 2002; 143(1): 37 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Somwar, W. Niu, D. Y. Kim, G. Sweeney, V. K. Randhawa, C. Huang, T. Ramlal, and A. Klip Differential Effects of Phosphatidylinositol 3-Kinase Inhibition on Intracellular Signals Regulating GLUT4 Translocation and Glucose Transport J. Biol. Chem., November 30, 2001; 276(49): 46079 - 46087. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakashima, P. M. Sharma, T. Imamura, R. Bookstein, and J. M. Olefsky The Tumor Suppressor PTEN Negatively Regulates Insulin Signaling in 3T3-L1 Adipocytes J. Biol. Chem., April 21, 2000; 275(17): 12889 - 12895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanzaki, R. T. Watson, N. O. Artemyev, and J. E. Pessin The Trimeric GTP-binding Protein (Gq/G11) alpha Subunit Is Required for Insulin-stimulated GLUT4 Translocation in 3T3L1 Adipocytes J. Biol. Chem., March 15, 2000; 275(10): 7167 - 7175. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imamura, K.-i. Ishibashi, S. Dalle, S. Ugi, and J. M. Olefsky Endothelin-1-induced GLUT4 Translocation Is Mediated via Galpha q/11 Protein and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes J. Biol. Chem., November 19, 1999; 274(47): 33691 - 33695. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imamura, P. Vollenweider, K. Egawa, M. Clodi, K. Ishibashi, N. Nakashima, S. Ugi, J. W. Adams, J. H. Brown, and J. M. Olefsky G Alpha-q/11 Protein Plays a Key Role in Insulin-Induced Glucose Transport in 3T3-L1 Adipocytes Mol. Cell. Biol., October 1, 1999; 19(10): 6765 - 6774. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen, R. V. Fucini, A. L. Olson, B. A. Hemmings, and J. E. Pessin Osmotic Shock Inhibits Insulin Signaling by Maintaining Akt/Protein Kinase B in an Inactive Dephosphorylated State Mol. Cell. Biol., July 1, 1999; 19(7): 4684 - 4694. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vollenweider, M. Clodi, S. S. Martin, T. Imamura, W. M. Kavanaugh, and J. M. Olefsky An SH2 Domain-Containing 5' Inositolphosphatase Inhibits Insulin-Induced GLUT4 Translocation and Growth Factor-Induced Actin Filament Rearrangement Mol. Cell. Biol., February 1, 1999; 19(2): 1081 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Khayat, T. Tsakiridis, A. Ueyama, R. Somwar, Y. Ebina, and A. Klip Rapid stimulation of glucose transport by mitochondrial uncoupling depends in part on cytosolic Ca2+ and cPKC Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1487 - C1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Janez, D. S. Worrall, T. Imamura, P. M. Sharma, and J. M. Olefsky The Osmotic Shock-induced Glucose Transport Pathway in 3T3-L1 Adipocytes Is Mediated by Gab-1 and Requires Gab-1-associated Phosphatidylinositol 3-Kinase Activity for Full Activation J. Biol. Chem., August 25, 2000; 275(35): 26870 - 26876. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |